GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicycle Therapeutics PLC (FRA:50BA) » Definitions » Total Premiums Earned

Bicycle Therapeutics (FRA:50BA) Total Premiums Earned


View and export this data going back to 2019. Start your Free Trial

What is Bicycle Therapeutics Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.


Bicycle Therapeutics Business Description

Traded in Other Exchanges
Address
Granta Park, Great Abington, Blocks A and B, Portway Building, Cambridge, GBR, CB21 6GS
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.